使用有针对性的降解器关闭STAT6
1Department of Chemistry and Biochemistry, The Ohio State University, 484 West 12th Ave., Columbus, Ohio 43210, United States.
Journal of medicinal chemistry
|February 20, 2025
概括
研究人员开发出一种强大而有选择性的STAT6降解剂,克服了数十年来针对信号传感器和转录6激活器 (STAT6) 的挑战,以治疗疾病而带来最小的副作用.
科学领域:
- 分子生物学分子生物学
- 药物发现 药物发现
- 药品化学 药品化学 是一个
背景情况:
- 信号转换器和转录激活器6 (STAT6) 是一种关键蛋白质,涉及各种人类疾病.
- 多年来,STAT6一直是药物开发的挑战性目标.
- 开发用于STAT6相关疾病的有效治疗方法仍然是一个重要的未满足的医疗需求.
研究的目的:
- 报告发现了一种新的STAT6降解剂.
- 为了描述已识别的STAT6降解剂的效力和选择性.
- 为了突出这种降解剂在治疗应用中的潜力.
主要方法:
- 使用了高通量查和药物化学优化.
- 生物化学和细胞测试被用来评估功效和选择性.
- 为了确保安全,进行了目标以外活动分析.
主要成果:
- 一种非常强效和选择性的STAT6降解剂被成功鉴定出来.
- 降解剂对非标蛋白具有极小的活性.
- 该化合物的特性表明它具有有前途的治疗特征.
结论:
- 这一发现代表了针对STAT6.6的突破.
- 这种强大而有选择性的STAT6降解剂提供了一个新的治疗途径.
- 这种化合物的进一步开发可能会导致各种疾病的新治疗方法.
相关概念视频
The JAK-STAT Signaling Pathway
8.6K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.6K
Regulated Protein Degradation
7.1K
It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
7.1K
TGF - β Signaling Pathway
7.2K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.2K
Amplifying Signals via Enzymatic Cascade
8.2K
When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
8.2K
PI3K/mTOR/AKT Signaling Pathway
3.4K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.4K
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K


